The use of prenatal ultrasound for the detection of fetal aneuploidy

Clinical Obstetrics and Gynecology

Volumn 51, Issue 1, 2008, Pages 48-61

  Holmgren, Calla ^a   Lacoursiere, Daphne Yvette ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Aneuploidy; Fetal diagnosis; Prenatal ultrasound

Indexed keywords

ANEUPLOIDY; BRAIN CYST; CHOROID PLEXUS CYST; CONGENITAL HEART DISEASE; CYSTIC LYMPHANGIOMA; DOWN SYNDROME; DUCTUS VENOSUS; ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; KIDNEY DISEASE; MULTIPLE PREGNANCY; NASAL BONE; PREGNANCY; PRENATAL PERIOD; PRENATAL SCREENING; RENAL PYELECTASIS; REVIEW; SECOND TRIMESTER PREGNANCY; STANDARDIZATION; TRIPLOIDY; TRISOMY 13; TRISOMY 18; TURNER SYNDROME; UTERUS; BLOOD; FEMALE; METHODOLOGY; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL DIAGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKER;

ANEUPLOIDY; BIOLOGICAL MARKERS; FEMALE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 41649092540     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e31816163e3     Document Type: Review

References (51)

1. Malone F, Canick JA, Ball RH, et al. First-trimester or second-trimester screening or both for Down's Syndrome. First- and Second- Trimester Evaluation of Risk (FASTER) Research Consortium. NEngl J Med. 2005;353:2001-2011.
2. Snijders RJ, Noble P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet. 1998;352:343-346.
3. Wapner R, Thom E, Simpson J, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med. 2003;349:1405-1413.
4. De Biasio P, Siccardi M, Volpe G, et al. First-trimester screening for Down syndrome using nuchal translucency measurement with free beta-hCG and PAPP-A between 10 and 13 weeks of pregnancy - the combined test. Prenat Diagn. 1999;19:360-363.
5. Niemimaa M, Heinonen S, Hippeläinen M, et al. First-trimester screening for Down's syndrome in in vitro fertilization pregnancies. Fertil Steril. 2001;76:1282-1283.
6. Krantz DA, Hallahan TW, Orlandi F, et al. First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency. Obstet Gynecol. 2000;96:207-213.
7. Schuchter K, Hafner E, Stangl G, et al. The first trimester "combined test" for the detection of Down syndrome pregnancies in 4939 unselected pregnancies. Prenat Diagn. 2002;22:211-215.
8. Hyett J, Thilaganathan B. First trimester screening for fetal abnormalities. Curr Opin Obstet Gynecol. 1999;11:563-569.
9. Bahado-Singh RO, Wapner R, Thom E, et al. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects. Am J Obstet Gynecol. 2005;192:1357-1361.
10. Souka AP, Krampl E, Bakalis S, et al. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol. 2001;18:9-17.
11. Ganapathy R, Guven M, Sethna F, et al. Natural history and outcome of prenatally diagnosed cystic hygroma. Prenat Diagn. 2004;24:965-968.
12. Malone FD, D'Alton ME. First-trimester sonographic screening for Down syndrome. Obstet Gynecol. 2003;102(5 Pt 1):1066-1079.
13. Cleary-Goldman J, Morgan MA, Malone F, et al. Screening for Down syndrome: practice patterns and knowledge of obstetricians and gynecologists. Obstet Gynecol. 2006;107:11-17.
14. Comstock CH, Malone FD, Ball R, et al. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening? Am J Obstet Gynecol. 2006;195:843-847.
15. Down JLH. Observations on an Ethnic Classification of Idiots. London Hospital Reports, 3:1866, S. 259-262.
16. Malone FD, Ball RH, Nyberg DA, et al. First-trimester nasal bone evaluation for aneuploidy in the general population. Obstet Gynecol. 2004;104:1222-1228.
17. Sonek JD, Cicero S, Neiger R, et al. Nasal bone assessment in prenatal screening for trisomy 21. Am J Obstet Gynecol. 2006;195:1219-1230.
18. Nicolaides KH, Snijders RJ, Gosden C, et al. Ultrasonographically detectable markers of fetal chromosomal abnormalities. Lancet. 1992;340:704-707.
19. Sickler GK, Nyberg DA, Sohaey R, et al. Polyhydramnios and fetal intrauterine growth restriction: ominous combination. J Ultrasound Med. 1997;16:609-614.
20. Gross SJ, Shulman LP, Tolley E, et al. Isolated fetal choroid plexus cysts and trisomy 18: a review and meta-analysis. Am J Obstet Gynecol. 1995;172(1 Pt 1):83-87.
21. Morcos CL, Platt LD, Carlson DE, et al. The isolated choroid plexus cyst. Obstet Gynecol. 1998;92:232-236.
22. Nyberg DA, Luthy DA, Resta RG, et al. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol. 1998;12:8-14.
23. Benacerraf BR, Neuberg D, Bromley B, et al. Sonographic scoring index for prenatal detection of chromosomal abnormalities. J Ultrasound Med. 1992;9:449-458.
24. Allan L. Antenatal diagnosis of heart disease. Heart. 2000;83:367.
25. Allan LD. Fetal congenital heart disease: diagnosis and management. Curr Opin Obstet Gynecol. 1994;6:45-49.
26. Tennstedt C, Chaoui R, Korner H, et al. Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study. Heart. 1999;82:34-39.
27. Bromley B, Lieberman E, Shipp T, et al. Echogenic intracardiac focus: a sonographic sign for fetal Down syndrome. Obstet Gynecol. 1995;86:998-1001.
28. Roberts DJ, Genest D. Cardiac histologic pathology characteristic of trisomies 13 and 21. Hum Pathol. 1992;23:1130-1140.
29. Shipp TD, Bromley B, Lieberman E, et al. The frequency of the detection of fetal echogenic intracardiac foci with respect to maternal race. Ultrasound Obstet Gynecol. 2000;15:460-462.
30. Sepulveda W, Sebire NJ. Fetal echogenic bowel: a complex scenario. Ultrasound Obstet Gynecol. 2000;16:510-514.
31. Nyberg DA, Dubinsky T, Resta R, et al. Echogenic fetal bowel during the second trimester: clinical importance. Radiology. 1993;188:527-531.
32. Bahado-Singh R, Morotti R, Copel J, et al. Hyperechoic fetal bowel: the perinatal consequences. Prenat Diagn. 1994;14:981-987.
33. Wickstrom E, Maizels M, Sabbagha R, et al. Isolated fetal pyelectasis: assessment of risk for postnatal uropathy and Down syndrome. Ultrasound Obstet Gynecol. 1996;8:236-240.
34. Benacerraf BR, Frigoletto FD, Jr, Cramer D, et al. Down syndrome: sonographic sign for diagnosis in the second-trimester fetus. Radiology. 1987;163:811-813.
35. Nisbet DL, Griffin DR, Chitty L, et al. Prenatal features of Noonan syndrome. Prenat Diagn. 1999;19:642-647.
36. Benacerraf BR, Frigoletto FD, Jr. Soft tissue nuchal fold in the second trimester fetus: standards for normal measurements compared to the fetus with Down syndrome. Am J Obstet Gynecol. 1987;157:1146-1149.
37. Jacobs PA, Melville M, Ratcliffe S, et al. A cytogenetic survey of 11,680 newborn infants. Ann Hum Genet. 1974;37:359-376.
38. Hook EB, Warburton D. The distribution of chromosomal genotypes associated with Turner's syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism. Hum Genet. 1983;64:24-27.
39. Nielsen J, Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet. 1991;87:81-83.
40. Bronshtein M, Zimmer EZ, Blazer S, et al. A characteristic cluster of fetal sonographic markers that are predictive of fetal Turner syndrome in early pregnancy. Am J Obstet Gynecol. 2003;188:1016-1020.
41. Sotiriadis A, Makrydimas G, Ioannidis J, et al. Diagnostic performance of intracardiac echogenic foci for Down syndrome: a meta-analysis. Obstet Gynecol. 2003;101(5 Pt 1):1009-1016.
42. Gupta JK, Khan KS, Thornton JG, et al. Management of fetal choroid plexus cysts. Br J Obstet Gynaecol. 1997;104:881-886.
43. Jones KL. Smith's Recognizable Patterns of Human Malformation, 6th ed. Philadelphia: Elsevier Saunders; 2006.
44. Papp C, Ban Z, Szigeti Z, et al. Role of second trimester sonography in detecting trisomy 18: a review of 70 cases. J Clin Ultrasound. 2007;35:68-72.
45. Nyberg DA, Kramer D, Resta R, et al. Prenatal sonographic findings of trisomy 18: review of 47 cases. J Ultrasound Med. 1993;12:103-113.
46. Papageorghiou AT, Avgidou K, Spencer K, et al. Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation. Am J Obstet Gynecol. 2006;194:397-401.
47. Demasio K, Canterino J, Ananth C, et al. Isolated choroid plexus cyst in low-risk women less than 35 years old. Am J Obstet Gynecol. 2002;187:1246-1249.
48. Lehman CD, Nyberg DA, Winter T III, et al. Trisomy 13 syndrome: prenatal US findings in a review of 33 cases. Radiology. 1995;194:217-222.
49. Jauniaux E, Kadri R, Hustin J, et al. Partial mole and triploidy: screening patients with first-trimester spontaneous abortion. Obstet Gynecol. 1996;88(4 Pt 1):616-619.
50. Sepulveda W, Sebire NJ, Nicolaides K, et al. Evolution of the lambda or twin-chorionic peak sign in dichorionic twin pregnancies. Obstet Gynecol. 1997;89:439-441.
51. Edwards MS, Ellings JM, Newman RB, et al. Predictive value of antepartum ultrasound examination for anomalies in twin gestations. Ultrasound Obstet Gynecol. 1995;6:43-49.